The Food and Drug Administration (FDA or Agency) is announcing the availability of a guidance for industry (GFI) #170 entitled ``Animal Drug User Fees and Fee Waivers and Reductions.'' This revised guidance document describes the types of fees that FDA is authorized to collect under the Animal Drug User Fee Act of 2003, as amended, and how to request waivers and reductions of these fees.
Document
Animal Drug User Fees and Fee Waivers and Reductions; Revised Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a guidance for industry (GFI) #170 entitled ``Animal Drug User Fees and Fee Waivers and Reduct...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
82 FR 34534
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Animal Drug User Fees and Fee Waivers and Reductions; Revised Guidance for Industry; Availability,” thefederalregister.org (July 25, 2017), https://thefederalregister.org/documents/2017-15536/animal-drug-user-fees-and-fee-waivers-and-reductions-revised-guidance-for-industry-availability.